Delivery Order SPE2DB24D2018-SPE2DB25FWUJ7
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,170.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Rexulti 2 mg tablet, a treatment for certain mental health conditions. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 21, 2025. The contract is not set aside for any specific type of business....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rexulti 2 mg tablets. The contract has a ceiling value of $6,417.44 and a period of performance through November 24, 2023. It is a firm-fixed-price contract and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rexulti 2 mg tablets. The contract has a ceiling value of $18,313.44 and an ultimate completion date of June 20, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,592.57 firm fixed-price contract is for the delivery of Rexulti 1 mg tablets, a psychiatric medication. The contract has an ultimate completion date of July 5, 2024 and was awarded on July 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,595.96, is for the delivery of the prescription medication Rexulti 0.5 mg tablet. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $30,591.65, is for the supply of Rexulti 1 mg tablets, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of the prescription drug Rexulti 2 mg tablets. The contract has a firm fixed price of $3,736.47 and a period of performance through January 31, 2025. The contract was not subject to any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,470.83 firm fixed-price contract is for the supply of the prescription drug Rexulti 2 mg tablets, with a period of performance through April 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,266.07, is for the supply of Rexulti 2 mg tablets. The contract has a period of performance through February 5, 2025 and uses a firm fixed-price pricing type. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which provides...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets. The contract has a fixed-price, delivery order structure and a ceiling value of $16,830.55. It has an ultimate completion date of July 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support medical needs of the U.S. government, likely for military treatment...